Lactobacillus gasseri BNR17 and Corrected Rapid Colon Transit Time

• A double blind, placebo-controlled, randomized clinical trial that breast milk derived-Lactobacillus gasseri BNR17 mitigated diarrhea-dominant irritable bowel syndrome

  • 2020-09-30
  • RCT · n = 24
  • Journal of Clinical Biochemistry and Nutrition 62(2)
  • • S. Shin
    • Yoon Mi Choi
    • W. Kim
    • S. Hong
    • Jong‐Min Park
    • Joohee Kim
    • O. Kwon
    • E. Lee
    • K. Hahm

  • PubMed: 29610559
  • DOI: 10.3164/jcbn.17-73

  12 Insights on

  • Corrected Rapid Colon Transit Time

  • High evidence
  • Rigorous Journal

  On comparative CTT before and after BNR17, 6 out of 24 subjects showed significant correction of rapid colon transit pattern, while only 2 out of 24 in placebo (p<0.01).

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes